TIS
Tissue Therapies
- Short interest
- 0.00%
- 0.00 pp 30d
- as of 20 Feb 2015
- Reported shorts
- 5K
- Shares on issue
- 282.406M
Tissue Therapies (TIS) financials
Results, ratios and statements
Fundamentals
Our data providers hold no financial statements for TIS (last checked 15 Oct 2026). The company's own filings are listed below.
Financial reports
The company's own filings, newest first
- Quarterly Activities Report and Cash Flow ReportQuarterly Report23 Apr 2026via asx_announcements
- Annual Report to shareholdersAnnual Report27 Mar 2026via asx_announcements
- Quarterly Activities Report and Cash Flow ReportQuarterly Report22 Jan 2026via asx_announcements
- Quarterly Activities Report and Cash Flow ReportQuarterly Report29 Oct 2025via asx_announcements
- Half Year AccountsHalf Year Results12 Sep 2025via asx_announcements
- Quarterly Activities Report and Cash Flow ReportQuarterly Report24 Jul 2025via asx_announcements
- Quarterly Activities Report and Cash Flow ReportQuarterly Report29 Apr 2025via asx_announcements
- Annual Report to shareholdersAnnual Report31 Mar 2025via asx_announcements
- Quarterly Activities Report and Cash Flow ReportQuarterly Report29 Jan 2025via asx_announcements
- Quarterly Activities Report and Cash Flow ReportQuarterly Report29 Oct 2024via asx_announcements
Showing 10 of 66 reports